Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Aurora Biosciences completes first stage of UHTSS for Warner-Lambert

Oct. 6, 1998

Merck KGaA, 3DP extend drug discovery agreement for another year

Oct. 5, 1998

Bayer, Millennium form the largest drug discovery alliance in history

Sep. 29, 1998

Tranzyme obtains technology license from U. of Alabama

Sep. 24, 1998

PowderJect delivery of DNA vaccines validated in preclinical study

Sep. 24, 1998

BTG licenses improved vaccine technology to Pasteur Merieux Connaught

Sep. 23, 1998

Lion and Infogen establish gene identification collaboration

Sep. 23, 1998

Genetronics reports continued success with electroporation therapy of cancer

Sep. 22, 1998

SB-234551 characterized as potent, selective, nonpeptide ETA receptor antagonist

Sep. 18, 1998

Nexell submits data requested by FDA

Sep. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....